SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008510
Filing Date
2022-03-31
Accepted
2022-03-31 16:43:16
Documents
83
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3019424
2 ex4-1.htm EX-4.1 25762
3 ex21-1.htm EX-21.1 5708
4 ex23-1.htm EX-23.1 4596
5 ex23-2.htm EX-23.2 4279
6 ex31-1.htm EX-31.1 11591
7 ex31-2.htm EX-31.2 11571
8 ex32.htm EX-32 9133
9 GRAPHIC form10-k_001.jpg GRAPHIC 1724
  Complete submission text file 0001493152-22-008510.txt   11408811

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE envb-20211231.xsd EX-101.SCH 72767
11 XBRL CALCULATION FILE envb-20211231_cal.xml EX-101.CAL 59331
12 XBRL DEFINITION FILE envb-20211231_def.xml EX-101.DEF 359179
13 XBRL LABEL FILE envb-20211231_lab.xml EX-101.LAB 610068
14 XBRL PRESENTATION FILE envb-20211231_pre.xml EX-101.PRE 492095
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1887825
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38286 | Film No.: 22793436
SIC: 2834 Pharmaceutical Preparations